Sopharma AD (WSE:SPH)
Poland flag Poland · Delayed Price · Currency is PLN
12.75
-0.25 (-1.92%)
Dec 4, 2025, 6:59 PM CET

Sopharma AD Revenue

Sopharma AD had revenue of 641.57M BGN in the quarter ending September 30, 2025, with 18.09% growth. This brings the company's revenue in the last twelve months to 2.51B, up 22.13% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.

Revenue (ttm)
2.51B BGN
Revenue Growth
+22.13%
P/S Ratio
0.57
Revenue / Employee
448.40K BGN
Employees
5,599
Market Cap
3.12B PLN

Revenue Chart

* This company reports financials in BGN.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.14B250.64M13.27%
Dec 31, 20231.89B217.31M13.00%
Dec 31, 20221.67B60.17M3.73%
Dec 31, 20211.61B165.21M11.42%
Dec 31, 20201.45B158.02M12.27%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Diagnostyka 2.30B
NEUCA 13.34B
Synektik Spólka Akcyjna 623.20M
Voxel 568.83M
Celon Pharma 225.60M
Selvita 373.90M
Ryvu Therapeutics 90.41M
Centrum Medyczne ENEL-MED 820.59M
Revenue Rankings